Kannapolis, North Carolina Clinical Trials

A listing of Kannapolis, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 19 clinical trials
Almond Supplementation and Exercise Recovery

The PURPOSE of this study is to see if eating almonds for four weeks will reduce muscle damage, soreness, and inflammation during several days of recovery from eccentric exercise.

  • 22 Jul, 2021
  • 1 location
A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis

This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult patients with active eosinophilic duodenitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of open-label lirentelimab …

Allakos Investigational Site
 (7.1 away) Contact site
  • 09 Sep, 2021
  • +37 other locations
Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes Patients

This study is a randomized, double-blind, placebo-controlled, dose-response study of BKR-017 and placebo that will be conducted at two investigative sites. The total duration of subject involvement is approximately 15 weeks; the screening period can be up to 3 weeks prior to the start of test period, followed by a …

insulin resistance
hemoglobin a1c
Duke Clinical & Translational Science Institute (CTSI)
 (1.7 away) Contact site
  • 04 Jul, 2021
  • +1 other locations
S1613 Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

This randomized phase II trial studies how well trastuzumab and pertuzumab work compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer that has spread from where it started to other places in the body and cannot be removed by surgery. Monoclonal antibodies, such as trastuzumab …

carcinoma in situ
antibody therapy
endocrine therapy
monoclonal antibody therapy
Atrium Health Cabarrus/LCI-Concord
 (10.0 away) Contact site
  • 20 May, 2021
  • +829 other locations
Effect of Palmitoleic Acid on C-reactive Protein

This clinical trial will test the effects of an n-7 monounsaturated fatty acid known as palmitoleic acid (POA) on a chronic inflammation marker in overweight subjects. The study will enroll male and female subjects from healthy populations with high levels of the inflammatory marker c-reactive protein (CRP). Investigators will then …

  • 29 Jan, 2021
  • 1 location
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

This phase II trial studies how well ramucirumab and paclitaxel or the FOLFIRI regimen (leucovorin calcium, fluorouracil, and irinotecan hydrochloride) work in treating patients with small bowel cancers that have spread extensively to other anatomic sites (advanced) or are no longer responding to treatment (refractory). Ramucirumab is a monoclonal antibody …

Atrium Health Cabarrus/LCI-Concord
 (10.0 away) Contact site
  • 22 May, 2021
  • +375 other locations
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk …

bowel preparation
screening colonoscopy
Northeast GI Research Division
 (6.2 away) Contact site
  • 22 Aug, 2021
  • +198 other locations
Study of Patients Receiving DUPIXENT for Atopic Dermatitis (AD)

A long-term observational registry in patients with atopic dermatitis (AD) initiating treatment with DUPIXENT (dupilumab)

Regeneron Investigational Site
 (10.0 away) Contact site
  • 15 Sep, 2021
  • +94 other locations
Comparison of Participants Who Received a CanGaroo Envelope Tyrx Envelope or no Envelope During CIED Implantation

The objective of this study is to gather information on participants returning at time of CIED change-out or revision who underwent a device implantation with either a CanGaroo envelope, Tyrx envelope, or no envelope.

Atrium Health
 (10.0 away) Contact site
  • 30 Jul, 2021
  • +10 other locations